Investment
Features
FeesSafety
Academy
More
Pluang+

Ethereum Foundation warns some tools may fail after Glamsterdam upgrade changes gas model

Market News
18 Sep 2026
Crypto Economy
View Source
Neutral
Ethereum Foundation warns some tools may fail after Glamsterdam upgrade changes gas model

The Ethereum Foundation has issued a warning that the upcoming Glamsterdam upgrade, which changes the gas model, could cause some wallets, indexers, and gas estimators to stop working properly. This alert is important for users and developers relying on these tools to manage transactions and network fees. The foundation advises caution and preparation ahead of the upgrade to avoid disruptions.

Ethereum's upcoming Glamsterdam upgrade is highlighted here with Pluang's market snapshot as of Sep 18, 2026 21:36 WIB: out of 50 major cryptocurrencies, 46 rose and 3 fell today. Notable movers include DOT (Polkadot) with a 9.96% gain and a typical hold time of 120 days, ONE (Harmony) up 9.17% but with 98% sell order activity, and ETC (Ethereum Classic) rising 9.00% with 99% buy order activity and a 67-day typical hold time.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
4 hours ago
Wells Fargo downgrades Netflix on weak viewer engagement and content concerns, cutting price target by 25%.

Wells Fargo downgrades Netflix on weak viewer engagement and content concerns, cutting price target by 25%.

Wells Fargo downgraded Netflix from "equal weight" to "underweight" citing weaker viewer engagement and concerns over content quality, which could pressure margins and valuation. The price target was cut to $57, implying a 25% downside from current l...

Analyst Insights
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App